1330 related articles for article (PubMed ID: 31124340)
21. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
Ma L; Wei J; Zeng Y; Liu J; Xiao E; Kang Y; Kang Y
Drug Deliv; 2022 Dec; 29(1):440-453. PubMed ID: 35099348
[TBL] [Abstract][Full Text] [Related]
22. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway.
Li WX; Chen X; Yang Y; Huang HM; Li HD; Huang C; Meng XM; Li J
Toxicology; 2017 Apr; 381():75-86. PubMed ID: 27818223
[TBL] [Abstract][Full Text] [Related]
23. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
He Y; Huang C; Sun X; Long XR; Lv XW; Li J
Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
[TBL] [Abstract][Full Text] [Related]
25. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
26. Hsa_circ_0072765 knockdown inhibits proliferation, activation and migration in transforming growth factor-beta (TGF-β)-induced hepatic stellate cells (HSCs) by the miR-197-3p/TRPV3 axis.
Jin Y; Guo X; Zhang R; Yan C
Histol Histopathol; 2023 Nov; 38(11):1295-1306. PubMed ID: 36714978
[TBL] [Abstract][Full Text] [Related]
27. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
Hu YB; Ye XT; Zhou QQ; Fu RQ
Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
[TBL] [Abstract][Full Text] [Related]
29. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
Liao J; Zhang Z; Yuan Q; Luo L; Hu X
Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
[TBL] [Abstract][Full Text] [Related]
30. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway.
Song LY; Ma YT; Fang WJ; He Y; Wu JL; Zuo SR; Deng ZZ; Wang SF; Liu SK
BMC Complement Altern Med; 2019 Jun; 19(1):138. PubMed ID: 31221141
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
Li J; Dong S; Ye M; Peng G; Luo J; Wang C; Wang J; Zhao Q; Chang Y; Wang H
Dig Dis Sci; 2021 Jan; 66(1):143-150. PubMed ID: 32144602
[TBL] [Abstract][Full Text] [Related]
33. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
34. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
[TBL] [Abstract][Full Text] [Related]
35. miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway.
Ma T; Cai X; Wang Z; Huang L; Wang C; Jiang S; Hua Y; Liu Q
Biomed Res Int; 2017; 2017():2670658. PubMed ID: 28691020
[TBL] [Abstract][Full Text] [Related]
36. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
39. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation.
Zhu H; He C; Zhao H; Jiang W; Xu S; Li J; Ma T; Huang C
FASEB J; 2020 Nov; 34(11):14558-14571. PubMed ID: 32946656
[TBL] [Abstract][Full Text] [Related]
40. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
